title: The case for postoperative PDE-5 inhibitor drug treatment after radical prostatectomy.
authors.affiliation: Department of Urology, Vita-Salute University, Milan, Italy.
authors.forename: Alberto
authors.initials: A
authors.lastname: Briganti
authors.forename: Andrea
authors.initials: A
authors.lastname: Gallina
authors.forename: Andrea
authors.initials: A
authors.lastname: Salonia
authors.forename: Guiseppe
authors.initials: G
authors.lastname: Zanni
authors.forename: Andrea
authors.initials: A
authors.lastname: Cestari
authors.forename: Giorgio
authors.initials: G
authors.lastname: Guazzoni
authors.forename: Patrizio
authors.initials: P
authors.lastname: Rigatti
authors.forename: Francesco
authors.initials: F
authors.lastname: Montorsi
mesh_terms: D004305:Dose-Response Relationship, Drug; D007172:Erectile Dysfunction / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D008297:Male; D058986:Phosphodiesterase 5 Inhibitors; D010726:Phosphodiesterase Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D011182:Postoperative Care; D011468:Prostatectomy / Q000009:adverse effects* / Q000379:methods*
chemical_list: D058986:Phosphodiesterase 5 Inhibitors; D010726:Phosphodiesterase Inhibitors